Advanced Enzyme Ownership

ADVENZYMES   348.60  0.20  0.06%   
Advanced Enzyme holds a total of 111.88 Million outstanding shares. Advanced Enzyme Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Advanced Enzyme in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Advanced Enzyme, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Enzyme Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Advanced Stock Ownership Analysis

About 56.0% of the company shares are held by company insiders. The book value of Advanced Enzyme was presently reported as 127.0. The company recorded earning per share (EPS) of 11.71. Advanced Enzyme Tech last dividend was issued on the 23rd of July 2025. The entity had 5:1 split on the 25th of May 2017. For more info on Advanced Enzyme Technologies please contact the company at 91 22 4170 3200 or go to https://www.advancedenzymes.com.

Advanced Enzyme Outstanding Bonds

Advanced Enzyme issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Advanced Enzyme Tech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Advanced bonds can be classified according to their maturity, which is the date when Advanced Enzyme Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Advanced Stock Analysis

When running Advanced Enzyme's price analysis, check to measure Advanced Enzyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Enzyme is operating at the current time. Most of Advanced Enzyme's value examination focuses on studying past and present price action to predict the probability of Advanced Enzyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Enzyme's price. Additionally, you may evaluate how the addition of Advanced Enzyme to your portfolios can decrease your overall portfolio volatility.